Americafirst Capital Management LLC cut its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 78.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,422 shares of the healthcare conglomerate’s stock after selling 5,257 shares during the period. Americafirst Capital Management LLC’s holdings in UnitedHealth Group were worth $278,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. BlackRock Inc. lifted its holdings in shares of UnitedHealth Group by 1.2% during the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares during the period. Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. FMR LLC lifted its holdings in shares of UnitedHealth Group by 2.1% during the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares during the period. Alliancebernstein L.P. lifted its holdings in shares of UnitedHealth Group by 2.3% during the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after purchasing an additional 174,290 shares during the period. Finally, TIAA CREF Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 3.9% during the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after purchasing an additional 223,524 shares during the period. 86.24% of the stock is owned by hedge funds and other institutional investors.

In other news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the transaction, the chief executive officer now owns 195,314 shares in the company, valued at $43,310,879.50. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. In the last 90 days, insiders sold 53,853 shares of company stock valued at $12,358,508. Company insiders own 0.89% of the company’s stock.

Several equities research analysts recently weighed in on the company. Leerink Swann reaffirmed a “buy” rating and set a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Cantor Fitzgerald raised their target price on UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. Oppenheimer raised their target price on UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a report on Wednesday, October 18th. Wells Fargo & Co reissued an “outperform” rating and issued a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Finally, Citigroup raised their target price on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $243.22.

UnitedHealth Group Inc (NYSE UNH) opened at $220.96 on Friday. UnitedHealth Group Inc has a 52-week low of $156.49 and a 52-week high of $250.79. The firm has a market capitalization of $218,580.00, a price-to-earnings ratio of 20.63, a PEG ratio of 1.26 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter last year, the business posted $2.11 earnings per share. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. sell-side analysts forecast that UnitedHealth Group Inc will post 12.51 EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://theolympiareport.com/2018/02/11/americafirst-capital-management-llc-sells-5257-shares-of-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.